BETH KIRBY: Open Payments
NPI 1912652736 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $802 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $539 |
| Neurocrine BioSciences, Inc. | 2 | $159 |
| Tris Pharma Inc | 5 | $117 |
| Alkermes, Inc. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Corium, LLC | 2 | $54 |
| Lundbeck LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Phadia US Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: VRAYLAR, INGREZZA, Dyanavel XR, REXULTI, Azstarys, ARISTADA, LYBALVI, Auvelity.
Industry payments across IL — which companies pay providers there.
